DaVita

DaVita Liabilities

The The Liabilities of DaVita (DVA) as of Nov 18, 2026 is 16.32 B USD. In the previous year, The Liabilities was 15.19 B USD — a change of 7.42% (higher).

Liabilities

16.32 BUSD

YoY

7.42%

Last updated:

In 2025, DaVita's total liabilities amounted to 16.32 B USD, a 7.42% difference from the 15.19 B USD total liabilities in the previous year.

The DaVita Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
14.08 B USD
Jan 1, 2019
13.81 B USD
Jan 1, 2020
14.09 B USD
Jan 1, 2021
14.75 B USD
Jan 1, 2022
14.70 B USD
Jan 1, 2023
14.15 B USD
Jan 1, 2024
15.19 B USD
Jan 1, 2025
16.32 B USD
The DaVita Liabilities history
YEARLiabilitiesYoY
16.32 BUSD+7.42%
15.19 BUSD+7.38%
14.15 BUSD-3.76%
14.70 BUSD-0.32%
14.75 BUSD+4.67%
14.09 BUSD+2.03%
13.81 BUSD-1.89%
14.08 BUSD+7.87%
13.05 BUSD+1.03%
12.92 BUSD+3.07%
12.53 BUSD+6.65%
11.75 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DaVita Stock analysis

What does DaVita do? DaVita Inc. is a company headquartered in Denver, Colorado, specializing in the provision and management of outpatient dialysis treatments (renal replacement therapy) and related services. The company was founded in 1999 and has since experienced impressive growth, with a presence in over ten countries worldwide. The history of DaVita traces back to the origin of its business model: outpatient dialysis treatment. This is a form of renal replacement therapy where patients can be treated outside of the hospital, in a dedicated center or even in their own homes. This type of dialysis is less intimidating compared to inpatient treatment in a hospital and can be much more flexible in terms of scheduling. DaVita took this idea and brought it to the market in the US and other countries, where it has proven to be extremely successful. Nowadays, DaVita operates in three main business segments. The first is the patient care segment, which focuses on providing dialysis treatments and related services. Here, DaVita offers outpatient dialysis centers where patients can receive regular treatment. Another important aspect of this segment is patient and family education, integrating them into the treatment process and helping them lead as normal a life as possible. The second core area is the pharmaceutical supply business. DaVita has an extensive network of facilities and suppliers, as well as its own pharmacies where the necessary medications for dialysis patients are manufactured and stored. DaVita also handles billing with insurance and other payment entities to ensure seamless patient care. The third core area of DaVita is the international supply company. Here, DaVita offers its services in over ten countries worldwide, including Mexico, Colombia, Brazil, Saudi Arabia, and Canada. DaVita has steadily expanded its international business in recent years and aims to have a presence in even more countries in the future. But DaVita does not limit itself to these three core areas. The company is also known for its innovative research and development efforts aimed at improving the treatment of kidney disease and developing new technologies. Products offered by DaVita include innovative dialysis devices, advanced care management software, and intelligent sensors for automated patient monitoring. In its over 20-year history, DaVita has overcome many challenges, including regulatory issues, economic fluctuations, and ever-growing competition. Despite these challenges, the company has steadily expanded its position in the industry and established itself as a leading provider of dialysis and related services. DaVita's success is based on a culture of results orientation and a strong commitment to improving patient outcomes. The company understands that each patient has unique needs and that the treatment of kidney disease requires a lifelong commitment. Therefore, DaVita emphasizes individual care and collaboration with patients and their families to ensure optimal care. Overall, DaVita is an innovative company specializing in the provision of dialysis treatments and related services. The company has overcome many challenges in its history and established itself as a leading provider of dialysis and related services. DaVita is committed to improving the quality of life for dialysis patients worldwide and continuously optimizing the treatment of kidney disease. DaVita is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing DaVita's Liabilities

DaVita's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating DaVita's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing DaVita's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

DaVita's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in DaVita’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about DaVita stock

The Liabilities of DaVita is 16.32 B USD in 2025.

The Liabilities of DaVita changed from 15.19 B USD to 16.32 B USD, representing a 7.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities DaVita since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's DaVita historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — DaVita

All Key Metrics — DaVita